California Life Sciences Political Action Committee

View

Source Type	Amount	Percentage
Other	$2.26M	94.1%
Committee	$80.3K	3.3%
Individual	$62K	2.6%
Total	$2.41M	100%

Itemized Group by Donor

Donor	Total Amount	% of Total
Science Corporation Other	~$X,XXX	0.4%
Ptc Therapeutics, Inc. Other	~$X,XXX	0.4%
Biomarin Other	~$X,XXX	0.4%
Max Hodak Executive at Science Corporation	~$X,XXX	0.4%
Daiichi Sankyo, Inc. Other	~$X,XXX	0.4%
Guardant Health, Inc. Other	~$X,XXX	0.4%
Horizon Pharma, Inc. Other	~$X,XXX	0.4%
Global Blood Therapeutics Other	~$X,XXX	0.3%
Alexion Pharmaceuticals, Inc. Other	~$X,XXX	0.3%
Exact Sciences Corp. Other	~$X,XXX	0.3%
Cortexyme, Inc. Other	~$X,XXX	0.3%
Theravance, Inc Other	~$X,XXX	0.3%
Abbott Diabetes Care Other	~$X,XXX	0.3%
Pricewaterhousecoopers Other	~$X,XXX	0.3%
Bd Biosciences Other	~$X,XXX	0.3%
Resmed, Inc. Other	~$X,XXX	0.3%
Medimmune, Inc Other	~$X,XXX	0.3%
Avanir Pharmaceuticals, Inc. Other	~$X,XXX	0.3%
Christian W. Nolet Partner at Ernst & Young Llp	~$X,XXX	0.3%
Gilead Other	~$X,XXX	0.2%
Bristol-Myers Squibb Other	~$X,XXX	0.2%
Ampac Fine Chemicals Other	~$X,XXX	0.2%
Latham & Watkins Other	~$X,XXX	0.2%
Merck & Co., Inc. Other	~$X,XXX	0.2%
Theravance Biopharma U.S., Inc. Other	~$X,XXX	0.2%

Page 3 of 36